Another runner forming 🤔

This one’s gaining momentum fast

April 15, 2026

*This email contains promotional content

Hey folks, Jeff Bishop here,

It’s a wild time to be in the markets.

Even with the U.S. apparently blockading the Strait of Hormuz, the S&P 500 is now within striking distance of its highs.

Tech led the way again yesterday, and a softer-than-expected inflation reading kept the bulls hungry.

This market keeps finding excuses to move higher.

But while the indexes have been grinding out gains, the kind of “tactical trade” setups I focus on have been absolutely exploding.

Friday’s idea ripped 50% by the close.

And yesterday’s setup stayed above 60% most of the day, and still closed up 45%:

That’s the kind of action we’re seeing right now.

And it’s exactly why I have my eyes on another opportunity heading into today’s session.

On deck:

-> A small-cap pharma with an FDA-approved product already on the market

-> New clinical data showing a 100% cure rate in a high-demand indication

-> A fresh filing with the FDA that could unlock a brand new revenue stream

-> And expanding distribution partnerships reaching tens of thousands of locations nationwide

On top of that, the stock just bounced 14% yesterday and is now up more than 23% over the last week.

That kind of momentum usually means something big is brewing.

And with several catalysts lining up, this is an idea you should get on your radar right away.

On that page, I laid out everything you need to know. Don’t miss it.

To Your Success,

(ALL are welcome)

DISCLAIMER: This publication is owned and operated by Sherwood Ventures LLC (“SV”). Full disclaimer: https://bullseyealerts.com/disclaimer/.

NOT INVESTMENT ADVICE: We are a financial publisher, not a registered investment advisor. Content provided is for informational, educational, and promotional purposes only and should not be considered investment advice or a recommendation to buy or sell any security.

*PAID PROMOTION/COMPENSATION DISCLOSURE: SV has received twenty five thousand dollars (cash) for a one day marketing program on April 15, 2026 for marketing efforts to increase public awareness of the company mentioned on this page HERE. Please scroll to the bottom for full disclosure details including historical records (if applicable). As SV has received compensation from companies, these parties have financial interests in the securities referenced. SV and its affiliates may buy, sell, or hold positions in securities mentioned at any time without notice.

RISK WARNING: Investing involves substantial risk. Securities discussed may be highly speculative and volatile. Past performance is not indicative of future results, and you may lose some or all of your investment. Always consult a licensed financial professional before making investment decisions.